Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 2002 Oct;55(10):774–777. doi: 10.1136/jcp.55.10.774

Comparison of API20C with molecular identification of Candida spp isolated from bloodstream infections

J Xu 1, B C Millar 1, J E Moore 1, R McClurg 1, M J Walker 2, J Evans 2, S Hedderwick 3, R McMullan 1
PMCID: PMC1769787  PMID: 12354806

Abstract

A study was carried out to compare the API20C technology with polymerase chain reaction amplification and direct sequencing of the short internal transcribed spacer region 2 (ITS2) for the identification of 58 isolates of invasive candida species obtained from patients with bloodstream infections over the seven year period 1994 to 2000. Overall, there was only one disagreement between the phenotypic and genotypic identification, where the API scheme identified the isolate as C albicans but the molecular method identified it as C dubliniensis. This study demonstrated that the API20C method is useful in the identification of Candida spp isolated from blood culture and that molecular methods do not enhance identifications made using the API20C scheme. However, for correct reporting of C dubliniensis, an emerging bloodborne pathogen, it is recommended that all isolates identified as C albicans by the API20C scheme are further examined phenotypically and/or genotypically.

Keywords: candida species, identification, molecular techniques, API20C


Candida species are important fungal pathogens in several patient populations, particularly when causing bloodstream infections. There have been recent reports on the misidentification of several candida species when using phenotypic identification techniques.1,2 More recently, molecular identification techniques for fungi have been described, which allow for more accurate and rapid identification of Candida spp based on differences within the ribosomal RNA.3 Of these methods, polymerase chain reaction (PCR) amplification of the short internal transcribed spacer 2 (ITS2) region has been described as a rapid and reliable method to characterise yeast infections. At present, most laboratories in the UK use a combination of microscopic tests together with a commercial test system, such as the API20C, API32C, or API candida schema for the identification of clinically important yeasts. Previous work4,5 showed that the API20C scheme was more reliable at identifying common (97%) and rare (88%) yeast isolates than the API32C scheme, which could reliably identify 92% of common yeasts and 85% of rare isolates, but there have been few data comparing the use of the API schemes with the recently described ITS sequence based identification methods. Therefore, this study aimed to carry out a comparison of the API20C identification scheme with molecular identification using the ITS rRNA regions. In addition, we wanted to evaluate laboratory parameters associated with these respective phenotypic and genotypic techniques, to help provide guidance on their advantages and disadvantages in diagnostic applications.

“Our study aimed to carry out a comparison of the API20C identification scheme with molecular identification using the internal transcribed spacer region rRNA regions”

MATERIALS AND METHODS

Candida spp isolates (n = 58) were obtained from the blood cultures of 58 patients with bloodborne candidiasis attending Belfast City Hospital during the period 1994 to 2000. All isolates were stored at −80°C in accordance with the method of Moore et al.6 Isolates were resuscitated from storage on to Sabouraud dextrose agar (Oxoid CM0041; Oxoid Ltd, Basingstoke, UK), and passaged at least twice before phenotypic and genotypic characterisation.

All DNA isolation procedures were carried out in a class II biological safety cabinet in a room geographically separate from that used to set up the reaction mixes and also from the “post-PCR” room to minimise the production of false positive results. Total genomic fungal DNA was extracted from a single colony using the Roche high purity PCR template kit (Roche Diagnostics, East Sussex, UK), in accordance with the manufacturer’s instructions, following pretreatment with lyticase (Boehringer Mannheim, East Sussex, UK), as described previously.7 All reaction mixes were set up in a PCR hood in a room separate from that used to extract DNA and the amplification and post-PCR rooms to minimise contamination. Reaction mixes (50 μl) were set up as follows: 10mM Tris/HCl, pH 8.3, 50mM KCl, 2.5mM MgCl2, 200μM (each) dATP, dCTP, dGTP, and dTTP, 1.25 U of Taq DNA polymerase (Amplitaq; Perkin Elmer, Cheshire, UK), 0.2μM (each) of the ITS2 region primers (ITS3/ITS4; namely: ITS3, 5`-GCA TCG ATG AAG AAC GCA GC-3` and ITS4 (reverse) 5`-TCC TCC GCT TAT TGA TAT GC-3`, as described previously),3 and 4 μl of DNA template. After a “hot start”, the reaction mixtures were subjected to the following thermal cycling parameters in a Perkin Elmer 2400 thermocycler: 96°C for three minutes, followed by 40 cycles of 96°C for one minute, 55°C for one minute, and 72°C for one minute, with a final extension at 72°C for 10 minutes. During each run molecular grade water (LAL Grade; Biowhittaker Inc, Walkersville, Maryland, USA) samples were included randomly as negative controls. Where there was disagreement between the phenotypic and genotypic result using the ITS2 region, a further PCR reaction was set up, amplifying the ITS1–5.8S–ITS2 region, using the primers ITS1 (forward) 5`-TCC GTA GGT GAA CCT GCG G-3` and ITS4 (reverse), as described above. After amplification, aliquots (15 μl) were removed from each reaction mixture and examined by electrophoresis (80 V, 45 minutes) in gels composed of 2% (wt/vol) agarose (Gibco, Paisley, UK) in TAE buffer (40mM Tris, 20mM acetic acid, 1mM EDTA, pH 8.3), stained with ethidium bromide (5 μg/100ml). Gels were visualised under ultraviolet illumination using a gel image analysis system (UVP Products, UK) and all images archived as digital (*.bmp) graphic files.

All amplicons were purified using a QIAquick PCR purification kit (Qiagen, Crawley, Sussex, UK) eluted in Tris/HCl (10mM, pH 8.5) before sequencing, particularly to remove dNTPS, polymerases, salts, and primers. For the short ITS2 region, the sequencing primer ITS3 was used in the forward direction and for the large ITS1–5.8S–ITS2 region, the ITS1 primer was used in the forward direction. In both cases, the sequencing primer was labelled with Cy-5` and was used in conjunction with the ALF Express II (Amersham-Pharmacia, Little Chalfont, Buckinghamshire, UK) using the Thermo Sequenase fluorescent labelled primer cycle sequencing kit with 7-deaza-dGTP (catalogue no: RPN 2438; Amersham Pharmacia Biotech) (96°°C for one minute, followed by 25 cycles of 96°C for 10 seconds, 50°C for five seconds, and 60°C for five seconds, followed by a 4°C hold). The resulting sequences obtained were compared with those stored in the GenBank Data system using BLAST alignment software (http://www.blast.genome.ad.jp/) and sequence homology identity determined in accordance with the criteria, as described previously by Goldenberger et al.8

Isolates were identified using the API20C scheme (bioMérieux, Les Halles, France), in accordance with the manufacturer’s instructions.

RESULTS AND DISCUSSION

Table 1 shows the phenotypic and genotypic characterisation of the isolates. Overall, there was only one disagreement between the phenotypic and genotypic identifications (isolate 23), where the API scheme identified this isolate as C albicans but the molecular method identified this as C dubliniensis. In this case, a larger section of the ITS1–5.8S–ITS2 region was sequenced to confirm the initial identification of the smaller ITS2 region.

Table 1.

Comparison of phenotypic and genotypic identification within a collection of 58 invasive Candida spp isolated over the seven year period, 1994–2000

Small ITS region (ITS3/ITS4)
Isolate number Phenotypic identification (API 20C) Molecular identification Base pairs % Homology
1 C albicans C albicans 295 100
2 C albicans C albicans 299 100
3 C albicans C albicans 290 100
4 C albicans C albicans 303 99
5 C albicans C albicans 302 99
6 C albicans C albicans 293 99
7 C parapsilosis C parapsilosis 276 99
8 C parapsilosis C parapsilosis 267 99
9 C tropicalis C tropicalis 295 100
10 C krusei Issachenkia orientalis* 289 99
11 C krusei Issachenkia orientalis* 271 99
12 C parapsilosis C parapsilosis 263 99
13 C krusei I orientalis* 271 99
14 C albicans C albicans 294 100
15 C tropicalis C tropicalis 289 99
16 C parapsilosis C parapsilosis 277 99
17 C glabrata C glabrata 320 99
18 C glabrata C glabrata 332 100
19 C albicans C albicans 393 100
20 C glabrata C glabrata 344 100
21 C albicans C albicans 264 100
22 C albicans C albicans 289 99
23 C albicans C dubliniensis 299 100
24 C albicans C albicans 259 100
25 C albicans C albicans 269 98
26 C albicans C albicans 280 100
27 C glabrata C glabrata 343 99
28 C albicans C albicans 271 100
29 C albicans C albicans 294 100
30 C albicans C albicans 299 100
31 C albicans C albicans 287 100
32 C glabrata C glabrata 357 100
33 C glabrata C glabrata 333 100
34 C glabrata C glabrata 376 100
35 C parapsilosis C parapsilosis 272 99
36 C glabrata C glabrata 300 100
37 C parapsilosis C parapsilosis 270 99
38 C parapsilosis C parapsilosis 271 99
39 C tropicalis C tropicalis 278 100
40 C dubliniensis C dubliniensis 285 100
41 C albicans C albicans 289 100
42 C albicans C albicans 283 100
43 C albicans C albicans 282 100
44 C albicans C albicans 300 100
45 C albicans C albicans 294 99
46 C albicans C albicans 294 100
47 C glabrata C glabrata 380 100
48 C albicans C albicans 294 100
49 C albicans C albicans 295 100
50 C glabrata C glabrata 384 100
51 C albicans C albicans 295 100
52 C albicans C albicans 283 100
53 C glabrata C glabrata 380 100
54 C glabrata C glabrata 375 99
55 C albicans C albicans 293 99
56 C glabrata C glabrata 376 100
57 C parapsilosis C parapsilosis 262 100
58 C albicans C albicans 295 99

*I orientalis is the teleomorphic and sexual form of C krusei. All sequences entered in GenBank for C krusei have been renamed as I orientalis. Resulting sequences for I orientalis, C dubliniensis, C tropicalis, C glabrata, C parapsilosis, and C albicans were subsequently deposited in GenBank with the respective accession numbers, AF417255, AF430249, AF441197 AF441198, AF441199, and AF441200. …ITS, internal transribed spacer region.

Over the past few years, molecular techniques have greatly enhanced the diagnosis of causal agents of infectious disease, particularly when the causal agent is difficult to culture and identify.9–11 The results from our present study suggest that such a molecular identification scheme may be useful in differentiating C dubliniensis from C albicans, but is of little benefit in relation to the other non-albicans Candida spp. In addition, molecular techniques may be of benefit for the rapid identification of yeasts. Table 2 compares various laboratory parameters of the API20C and PCR schema, as experienced in our study, in the identification of Candida spp.

Table 2.

Comparison of laboratory parameters of API20C and PCR sequencing techniques

Laboratory parameter PCR sequence identification API20C
Time to result
    Culture time 72 hours
    DNA extraction 1 hour
    PCR amplification 3 hours
    Agarose gel electrophoresis 15 minutes
    Clean up of PCR product
    Sequencing protocol 16 hours (overnight)
Total time 20 hours 15 minutes 72 hours5
Relative cost/isolate High Moderate
Ease of use Complex Simple
Repeatability Excellent Good
Subjectivity Low Moderate
Requirements for complex equipment High Low
Applicability to routine diagnostic laboratory Poor Good

Because previous studies have shown that C dubliniensis is often present in mixed cultures with C albicans,12 it is important that routine diagnostic laboratories have the ability to differentiate between these two species. To date, the main problem has been in the selection of representative colonies of C dubliniensis from primary plates, before isolates are further characterised to the species level. There have been numerous reports of various phenotypic tests that have been used in an attempt to differentiate between these two species. These tests, including characteristic appearance on indicator media, chlamydospore formation, growth/restricted growth at raised temperature, carbohydrate assimilation, and intracellular β-D-glucosidase activity, have had varying degrees of success.12 Initially, it was suggested that the use of CHROMagar was a suitable means of discrimination; however, subsequent studies have shown this phenotypic characteristic to be an unreliable marker.12,13 Tintelnot and colleagues12 found that a more reliable phenotypic test was growth at increased temperature (42°C), where 117 of 117 C albicans and 53 of 53 C dubliniensis isolates were able to grow and not grow, respectively. However, Tintelnot and colleagues12 and other workers13 have shown that increased growth temperature cannot be used as the sole marker on all occasions.

“Molecular differentiation may be of increasing importance, given the emerging role of C dubliniensis in the current literature”

Take home messages.

  • The API20C technology was compared with polymerase chain reaction amplification and direct sequencing of the short internal transcribed spacer region (ITS2) for the identification of 58 isolates of invasive candida species

  • Overall, there was only one disagreement: the API scheme identified the isolate as C albicans but the molecular method identified it as C dubliniensis.

  • Thus, the API20C method is useful in the identification of Candida spp isolated from blood culture and molecular methods do not enhance its use

  • However, for correct reporting of C dubliniensis, an emerging bloodborne pathogen, we recommend that all isolates identified as C albicans by the API20C scheme are further examined phenotypically and/or genotypically

Consequently, because of the variable phenotypic results and evidence of the presence of atypical C albicans organisms, various workers have examined the usefulness of molecular assays to aid in the discrimination of these two species.14–17 Of these, the method of Elie and colleagues14 is particularly useful because it does not rely on colony picking from primary plates, and DNA can be extracted from the entire candida flora represented on the plate and differentiated by the use of specific probes. Such molecular differentiation may be of increasing importance, given the emerging role of C dubliniensis in the current literature.18

In conclusion, our study demonstrated that the API20C is a useful method in the identification of Candida spp isolated from blood culture and that molecular methods do not enhance API20C identification. However, for correct reporting of C dubliniensis, we recommend that all isolates identified as C albicans by the API20C scheme are further examined phenotypically and/or genotypically.

Acknowledgments

The authors thank Dr P Rooney, Northern Ireland Public Health Laboratory, for critically appraising this manuscript. This work was funded in part by the Northern Ireland Adult Cystic Fibrosis Centre and the Irish Cystic Fibrosis Association.

Abbreviations

  • ITS, internal transcribed spacer region

  • PCR, polymerase chain reaction

REFERENCES

  • 1.Rowen JL, Tate JM, Nordoff N, et al. Candida isolates from neonates: frequency of misidentification and reduced fluconazole susceptibility. J Clin Microbiol 1999;37:3735–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Reilly AA, Salkin IF, McGinnis MR, et al. Evaluation of mycology laboratory proficiency testing. J Clin Microbiol 1999;37:2297–305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Lott TJ, Kuykendall RJ, Reiss E. Nucleotide sequence analysis of the 5.8S rDNA and adjacent ITS2 region of Candida albicans and related species. Yeast 1993;9:1199–206. [DOI] [PubMed] [Google Scholar]
  • 4.Chen YC, Eisner JD, Kattar MM, et al. Identification of medically important yeasts using PCR-based detection of DNA sequence polymorphisms in the internal transcribed spacer 2 region of the rRNA genes. J Clin Microbiol 2000;6:2302–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ramani R, Gromadzki S, Pincus DH, et al. Efficacy of API 20C and ID 32C systems for identification of common and rare clinical yeast isolates. J Clin Microbiol 1998;11:3396–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Moore JE, Shaw AB, Stanley T, et al. Long-term preservation of strains of Burkholderia cepacia, Pseudomonas spp. and Stenotrophomonas maltophilia isolated from patients with cystic fibrosis. Lett Appl Microbiol 2001;33:82–3. [DOI] [PubMed] [Google Scholar]
  • 7.Millar BC, Jiru X, Moore JE, et al. A simple and sensitive method to extract bacterial, yeast and fungal DNA from blood culture material. J Microbiol Methods 2000;42:139–47. [DOI] [PubMed] [Google Scholar]
  • 8.Goldenberger D, Kunzli A, Vogt P, et al. Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J Clin Microbiol 1997;35:2733–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Millar B, Moore J, Mallon P, et al. Molecular diagnosis of infective endocarditis—a new Duke’s criterion. Scand J Infect Dis 2001;33:673–80. [DOI] [PubMed] [Google Scholar]
  • 10.Rantakokko-Jalava K, Nikkari S, Jalava J, et al. Direct amplification of rRNA genes in diagnosis of bacterial infections. J Clin Microbiol 2000;38:32–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ferrer C, Colom F, Frasés S, et al. Detection and identification of fungal pathogens by PCR and by ITS2 and 5.8S ribosomal DNA typing in ocular infections. J Clin Microbiol 2001;39:2873–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Tintelnot K, Haase G, Seibold M, et al. Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J Clin Microbiol 2000;38:1599–608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Pinjon E, Sullivan D, Salkin I, et al. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J Clin Microbiol 1998;36:2093–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Elie CM, Lott TJ, Reiss E, et al. Rapid identification of Candida species with species-specific DNA probes. J Clin Microbiol 1998;36:3260–5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Donnelly SM, Sullivan DJ, Shanley DB, et al. Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. Microbiology 1999;145:1871–82. [DOI] [PubMed] [Google Scholar]
  • 16.Kurzai O, Heinz WJ, Sullivan DJ, et al. Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans. J Clin Microbiol 1999;37:1587–90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Tamura M, Watanabe K, Mikami Y, et al. Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron. J Clin Microbiol 2001;39:4309–15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ponton J, Ruchel R, Clemons KV, et al. Emerging pathogens. Med Mycol 2000;38S(suppl 1):225–36. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES